IMMUNIC, INC. — Director's Dealing 2022

Jun 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2022-06-15

Reporting Person: Neermann Joerg (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-15	Stock Option	$3.40	A	10000	Acquired	2032-06-15	Common Stock (10000)	Direct

Footnotes

F1: The option vests in monthly increments over a period of one year from the grant date.